Search

everythinglearnresearchcommunity

for

Search:↓

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

IL-10 may worsen alopecia areata instead of helping it.

Alopecia areata patients often have low vitamin D levels.

Engineering strategies improve stem cells' ability to heal wounds effectively.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Vitiligo and alopecia areata may have similar causes despite their differences.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

Pu-erh tea reduces hair loss risk in offspring.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Hair helps prevent scalp skin cancer by supporting immune protection.

Hair protects the scalp from skin cancer by aiding immune defense.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Dupilumab can cause psoriasis in some patients.

COVID-19 vaccines can cause mild to moderate skin reactions, mostly after the first dose.

3D human skin models show promise for dermatology but face challenges in standardization and cost.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.